Sofiva Genomics Co.,Ltd. 6615.TWO Stock
Sofiva Genomics Co.,Ltd. Price Chart
Sofiva Genomics Co.,Ltd. 6615.TWO Financial and Trading Overview
Sofiva Genomics Co.,Ltd. stock price | 51.3 TWD |
Previous Close | 40.7 TWD |
Open | 40.5 TWD |
Bid | 40.4 TWD x 0 |
Ask | 40.6 TWD x 0 |
Day's Range | 40.35 - 40.65 TWD |
52 Week Range | 36.05 - 50 TWD |
Volume | 31.86K TWD |
Avg. Volume | 56.72K TWD |
Market Cap | 861.97M TWD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 26.201298 |
EPS (TTM) | 0.92 TWD |
Forward Dividend & Yield | 2 (4.95%) |
Ex-Dividend Date | July 7, 2023 |
1y Target Est | N/A |
6615.TWO Valuation Measures
Enterprise Value | 869.45M TWD |
Trailing P/E | 26.201298 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.3749275 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Sofiva Genomics Co.,Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -11.23% |
S&P500 52-Week Change | 20.43% |
52 Week High | 50 TWD |
52 Week Low | 36.05 TWD |
50-Day Moving Average | 41 TWD |
200-Day Moving Average | 39.42 TWD |
6615.TWO Share Statistics
Avg. Volume (3 month) | 56.72K TWD |
Avg. Daily Volume (10-Days) | 37.9K TWD |
Shares Outstanding | 21.36M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 48.41% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | 350.00% |
Payout Ratio | 1.3072 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 23.21 TWD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 148.99M TWD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 1.54 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 29.347 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Sofiva Genomics Co.,Ltd.
Country | Taiwan |
State | N/A |
City | Taipei |
Address | No. 27, Baoqing Road |
ZIP | 10043 |
Phone | 886 2 2382 6615 |
Website | https://www.sofivagenomics.com.tw |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping. It also provides cancer services, such as cancer scans; real-time monitoring of tumor dynamics; hereditary cancer related genetic tests; and hereditary women's cancer tests for breast, colon, ovarian, and endometrial cancer, as well as human papillomavirus screening. In addition, the company offers rare diseases genetic testing services; and preimplantation genetic diagnosis and NGS-based preimplantation genetic screening services. Further, it provides new-born genetic testing services comprising baby scans; hereditary sensorineural hearing loss screening; congenital central hypoventilation syndrome screening; congenital cytomegalovirus infection screening test; and atopic dermatitis genetic screening. Additionally, the company offers biochemical and chromosome testing, as well as advisory and support services. It serves expectant parents, patients with genetic disorders, and their families. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.
Q&A For Sofiva Genomics Co.,Ltd. Stock
What is a current 6615.TWO stock price?
Sofiva Genomics Co.,Ltd. 6615.TWO stock price today per share is 51.3 TWD.
How to purchase Sofiva Genomics Co.,Ltd. stock?
You can buy 6615.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sofiva Genomics Co.,Ltd.?
The stock symbol or ticker of Sofiva Genomics Co.,Ltd. is 6615.TWO.
Which industry does the Sofiva Genomics Co.,Ltd. company belong to?
The Sofiva Genomics Co.,Ltd. industry is Diagnostics & Research.
How many shares does Sofiva Genomics Co.,Ltd. have in circulation?
The max supply of Sofiva Genomics Co.,Ltd. shares is 21.36M.
What is Sofiva Genomics Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Sofiva Genomics Co.,Ltd. PE Ratio is 55.76086800 now.
What was Sofiva Genomics Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Sofiva Genomics Co.,Ltd. EPS is 0.92 TWD over the trailing 12 months.
Which sector does the Sofiva Genomics Co.,Ltd. company belong to?
The Sofiva Genomics Co.,Ltd. sector is Healthcare.